pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
BIOS: GM I
GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency)
Sylamore Bio
0 catalysts
Preclinical
BIOS:MPS I
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Sylamore Bio
0 catalysts
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)
LABS JUVISE
0 catalysts
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE
BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (BISOPROLOL FUMARATE)
← prev
page 67 of 271
next →
131
Pain89
Neurology1
Aurobindo Pharma Ltd
0 catalysts
Phase 1
BJ-001
Solid Tumor
BJ Bioscience Inc
0 catalysts
Phase 1
BJ-005
Solid Tumor
BJ Bioscience Inc
0 catalysts
BKEMV
BKEMV (ECULIZUMAB-AEEB)
1 INDICATIONS AND USAGE BKEMV is a complement inhibitor indicated for: The tr…
Complement C5
$AMGNAMGEN INC
0 catalysts
Phase 2
BLB-101
Coronavirus Disease 2019 (COVID-19)
Blue Lake Biotechnology Inc
0 catalysts
Phase 2
BLB-201
Respiratory Syncytial Virus (RSV) Infections
Blue Lake Biotechnology Inc
0 catalysts
BLENREP
BLENREP (BELANTAMAB MAFODOTIN-BLMF)
GlaxoSmithKline LLC
0 catalysts
BLINCYTO
BLINCYTO (BLINATUMOMAB)
1 INDICATIONS AND USAGE BLINCYTO is a bispecific CD19-directed CD3 T-cell eng…
B-lymphocyte antigen CD19T cell surface glycoprotein CD3
$AMGNAMGEN INC
0 catalysts
Phase 1
BLM-11D1
Refractory Acute Myeloid Leukemia
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 1
BLM-14D1
Gastrointestinal Tumor
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 1
BLM-17D1
Endometrial Cancer
Sichuan Biokin Pharmaceutical Co Ltd
0 catalysts
Phase 2
BLU-808
Chronic Inducible Urticaria
Blueprint Medicines Corp
0 catalysts
BLUDIGO
BLUDIGO (INDIGOTINDISULFONATE SODIUM)
PROVEPHARM SAS
0 catalysts
BLUJEPA
BLUJEPA (GEPOTIDACIN MESYLATE)
GlaxoSmithKline LLC
0 catalysts
Preclinical
BMD-001
Alzheimer's Disease
Biorchestra Co Ltd
0 catalysts
Phase 1
BMF-650
Obesity
$BMEABiomea Fusion, Inc.
0 catalysts
Phase 2
BMND-08
Alzheimer's Disease
Biomind Labs Inc
0 catalysts
Phase 1
BMS-986416
Diffuse Cutaneous Systemic Sclerosis
Bristol-Myers Squibb Co
0 catalysts
Phase 2
BMS-986446
Alzheimer's Disease
Bristol-Myers Squibb Co
0 catalysts
Phase 1
BMS-986497
Myelodysplastic Syndrome (Preleukemia)
Bristol-Myers Squibb Co
0 catalysts
Phase 2
BMX-001
High-Grade Glioma
Biomimetix JV LLC
0 catalysts
Phase 2
BNT-111
Metastatic Melanoma
$BNTXBioNTech SE
0 catalysts
Phase 3
BNT-113
Recurrent Head And Neck Squamous Cell Carcinoma
$BNTXBioNTech SE
0 catalysts
Phase 2
BOLD-100
Colorectal Cancer
Bold Therapeutics Inc
0 catalysts
Phase 2
BORTEZOMIB
BORTEZOMIB (BORTEZOMIB)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Millennium Pharmaceuticals Inc
0 catalysts
Phase 2
BOXR-1030
Merkel Cell Carcinoma
SOTIO Biotech AS
0 catalysts
Phase 1
BP-1002
Refractory Acute Myeloid Leukemia
$BPTHBIO-PATH HOLDINGS, INC.
0 catalysts